Chronic active Epstein-Barr virus disease: Difference between revisions
From IDWiki
(Created page with "== Background == * Life-threatening infection with Epstein-Barr virus involving NK and T cells === Pathophysiology === * EBV infection involving B, T, or NK cells ===...") |
No edit summary |
||
Line 1: | Line 1: | ||
== |
==Background== |
||
* |
*Life-threatening inflammatory disorder and lymphoid neoplasm caused by infection with [[Epstein-Barr virus]] involving NK and T cells |
||
=== |
===Pathophysiology=== |
||
* |
*EBV infection involving B, T, and/or NK cells |
||
=== |
===Epidemiology=== |
||
* |
*Most cases reported in Japan and East Asia |
||
* |
*In the Americas, more common in Indigenous populations |
||
*However, can occur in people of all ethnicities |
|||
== |
==Clinical Manifestations== |
||
*Symptoms include fever, liver dysfunction, [[splenomegaly]], [[lymphadenopathy]], and [[thrombocytopenia]] |
*Symptoms include fever, liver dysfunction, [[splenomegaly]], [[lymphadenopathy]], and [[thrombocytopenia]] |
||
*May also have [[hepatomegaly]], [[anemia]], mosquito bite hypersensitivity, rashes, oral ulcers, [[hemophagocytic lymphohistiocytosis]], coronary artery aneurysm, liver failure, [[lymphoma]], and [[interstitial pneumonia]] |
*May also have [[hepatomegaly]], [[anemia]], mosquito bite hypersensitivity, rashes, oral ulcers, [[hemophagocytic lymphohistiocytosis]], coronary artery aneurysm, liver failure, [[lymphoma]], and [[interstitial pneumonia]] |
||
*Occasionally has [[uveitis]], CNS disease, intestinal perforation, and [[myocarditis]] |
*Occasionally has [[uveitis]], CNS disease, intestinal perforation, and [[myocarditis]] |
||
*Can progress to frank [[lymphoma]] or [[hemophagocytic lymphohistiocytosis]] |
|||
== |
=== Related Disorders === |
||
==== Severe mosquito bite allergy ==== |
|||
⚫ | |||
⚫ | |||
* A severe hypersensitivity reaction to saliva in the bite of [[Aedes albopictus]] mosquitoes |
|||
* Characterized by local skin inflammation followed by high fever, lymphadenopathy, and liver dysfunction |
|||
* The bite can ulcerate and scar |
|||
* Resoves within a month |
|||
==== Hydroa vacciniforme ==== |
|||
* Characterized by light-induced vesicles |
|||
* Can also involve systemic inflammation |
|||
== Diagnostic Criteria == |
|||
* Sustained or recurrent [[Infectious mononucleosis|IM‐like]] symptoms for greater than 3 months |
|||
** Symptoms include fever, lymphadenopathy, and hepatosplenomegaly, and possibly other symptoms |
|||
* Elevated EBV genome load in the peripheral blood (>10<sup>2.5</sup> copies/µg DNA) |
|||
* EBV infection of T or NK cells in the affected tissues or peripheral blood |
|||
* Exclusion of other possible diagnoses including the following: |
|||
** Primary EBV infection (infectious mononucleosis) |
|||
** [[Primary immunodeficiencies]] |
|||
** [[HIV]] |
|||
** Iatrogenic immunosuppression |
|||
** Autoimmune or collagen vascular diseases |
|||
** Other malignant [[lymphoma]] (classic [[Hodgkin lymphoma]], extranodal NK/T cell lymphoma, including nasal type, peripheral T cell lymphomas, and aggressive NK‐cell leukemia) |
|||
== Diagnosis == |
|||
* Can follow a series of stepwise diagnostic tests: |
|||
** Anti-EBV antibodies demonstrating anti-VCA-IgG (necessary for diagnosis), anti-EA-IgG, and anti-VCA-IgA or anti-EA-IgA antibodies |
|||
*** Anti-EBNA antibodies may be negative |
|||
** EBV DNA viral load ≥10<sup>2.5</sup> copies/μg DNA |
|||
** Detection of EBV infection of T or NK cells in affected tissues or peripheral blood |
|||
==Management== |
|||
⚫ | |||
⚫ | |||
== Further Reading == |
|||
* Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development. ''Front Pediatr''. 2019;7:14. doi: [https://doi.org/10.3389/fped.2019.00014 10.3389/fped.2019.00014] |
|||
[[Category:Hematology]] |
[[Category:Hematology]] |
Revision as of 01:34, 16 October 2020
Background
- Life-threatening inflammatory disorder and lymphoid neoplasm caused by infection with Epstein-Barr virus involving NK and T cells
Pathophysiology
- EBV infection involving B, T, and/or NK cells
Epidemiology
- Most cases reported in Japan and East Asia
- In the Americas, more common in Indigenous populations
- However, can occur in people of all ethnicities
Clinical Manifestations
- Symptoms include fever, liver dysfunction, splenomegaly, lymphadenopathy, and thrombocytopenia
- May also have hepatomegaly, anemia, mosquito bite hypersensitivity, rashes, oral ulcers, hemophagocytic lymphohistiocytosis, coronary artery aneurysm, liver failure, lymphoma, and interstitial pneumonia
- Occasionally has uveitis, CNS disease, intestinal perforation, and myocarditis
- Can progress to frank lymphoma or hemophagocytic lymphohistiocytosis
Related Disorders
Severe mosquito bite allergy
- A severe hypersensitivity reaction to saliva in the bite of Aedes albopictus mosquitoes
- Characterized by local skin inflammation followed by high fever, lymphadenopathy, and liver dysfunction
- The bite can ulcerate and scar
- Resoves within a month
Hydroa vacciniforme
- Characterized by light-induced vesicles
- Can also involve systemic inflammation
Diagnostic Criteria
- Sustained or recurrent IM‐like symptoms for greater than 3 months
- Symptoms include fever, lymphadenopathy, and hepatosplenomegaly, and possibly other symptoms
- Elevated EBV genome load in the peripheral blood (>102.5 copies/µg DNA)
- EBV infection of T or NK cells in the affected tissues or peripheral blood
- Exclusion of other possible diagnoses including the following:
- Primary EBV infection (infectious mononucleosis)
- Primary immunodeficiencies
- HIV
- Iatrogenic immunosuppression
- Autoimmune or collagen vascular diseases
- Other malignant lymphoma (classic Hodgkin lymphoma, extranodal NK/T cell lymphoma, including nasal type, peripheral T cell lymphomas, and aggressive NK‐cell leukemia)
Diagnosis
- Can follow a series of stepwise diagnostic tests:
- Anti-EBV antibodies demonstrating anti-VCA-IgG (necessary for diagnosis), anti-EA-IgG, and anti-VCA-IgA or anti-EA-IgA antibodies
- Anti-EBNA antibodies may be negative
- EBV DNA viral load ≥102.5 copies/μg DNA
- Detection of EBV infection of T or NK cells in affected tissues or peripheral blood
- Anti-EBV antibodies demonstrating anti-VCA-IgG (necessary for diagnosis), anti-EA-IgG, and anti-VCA-IgA or anti-EA-IgA antibodies
Management
- Hematopoietic stem cell transplantation is the only curative treatment
- Symptoms may be temporarily improved with corticosteroids
Further Reading
- Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development. Front Pediatr. 2019;7:14. doi: 10.3389/fped.2019.00014